Dialysis patients' fluid overload, antihypertensive medications, and obesity

ASAIO Journal

Volumn 57, Issue 6, 2011, Pages 511-515

  Tapolyai, Mihály ^a   Faludi, Mária ^a   Réti, Virág ^a   Lengvárszky, Zsolt ^b   Szarvas, Tibor ^b   Berta, Klára ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIO-IMPEDANCE; BODY FATS; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDY; DEGREE OF HYDRATION; HEMODIALYSIS PATIENT; POSITIVE CORRELATIONS; RISK FACTORS; SYSTOLIC BLOOD PRESSURE; T-TESTS;

BLOOD; BLOOD PRESSURE; HEMODIALYZERS; NUTRITION;

DIALYSIS;

ANTIHYPERTENSIVE AGENT;

ARTICLE; BODY FLUID; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; IMPEDANCE; MALE; METABOLIC DISORDER; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ANTIHYPERTENSIVE AGENTS; BODY FLUIDS; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; RENAL DIALYSIS; RISK FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 80455122707     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3182377216     Document Type: Article

References (28)

1. Zager PG, Nikolic J, Brown RH, et al: "U" curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 54:561-569, 1998.
2. Port FK, Hulbert-Shearon TE, Wolfe RA, et al: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 3:507-517, 1999.
3. Salem MM: Hypertension in the haemodialysis population: Any relationship to 2-years survival? Nephrol Dial Transplant 14:125-128, 1999.
4. Molnar MZ, Lukowskya LR, Streja E, et al: Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease. J Hypertens 28:2475-2484, 2010.
5. Zoccali C, Mallamaci F, Tripepi G, et al: Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. J Hypertens 17:1751-1758, 1999.
6. Mazzuchi N, Carbonell E, Fernández-Cean J: Importance of blood pressure control in hemodialysis patient survival. Kidney Int 58:2147-2154, 2000.
7. Foley RN, Agarwal R: Hypertension is harmful to dialysis patients and should be controlled. Semin Dial 20:518-522, 2007.
8. Ok E, Mees EJ: Unpleasant truths about salt restriction. Semin Dial 23:1-3, 2010.
9. Charra B: Fluid balance, dry weight, and blood pressure in dialysis. Hemodial Int 11:21-31, 2007.
10. Wizemann V, Wabel P, Chamney P, et al: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24:1574-1579, 2009.
11. Fisch BJ, Spiegel DM: Assessment of excess fluid distribution in chronic hemodialysis patients using bioimpedance spectroscopy. Kidney Int 49:1105-1109, 1996.
12. Jaeger JQ, Mehta RL: Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 10:392-403, 1999.
13. Yu SJ, Kim DH, Oh DJ, et al: Assessment of fluid shifts of body compartments using both bioimpedance analysis and blood volume monitoring. J Korean Med Sci 21:75-80, 2006.
14. Chanchairujira T, Mehta RL: Assessing fluid change in hemodialysis: Whole body versus sum of segmental bioimpedance spectroscopy. Kidney Int 60:2337-2342, 2001.
15. BCM-Body Composition Monitor: Operating Instructions, edition: 7/05.10, Software version: 3.2. Bad Homburg, Germany, Fresenius Medical Care.
16. Hanai T: Electrical properties of emulsions, in Sherman PH (ed), Emulsion Science. London, Academic, 1968, pp. 354-477.
17. Leypoldt JK, Cheung AK, Delmez JA, et al: Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 61:266-275, 2002.
18. Chazot C, Charra B, Laurent G, et al: Interdialysis blood pressure control by long haemodialysis sessions. Nephrol Dial Transplant 10:831-837, 1995.
19. Katzarski KS, Charra B, Luik AJ, et al: Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 14:369-375, 1999.
20. Tapolyai M, Karim J, Fakhruddin A: Escalating antihypertensive medications in end-stage renal disease patients does not improve blood pressure control. J Clin Hypertens (Greenwich) 10:215-218, 2008.
21. Available at: http://www.kidney.org/professionals/KDOQI/guidelines-cvd/ guide12.htm. Accessed 2005.
22. Hörl MP, Hörl WH: Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis 39:227-244, 2002.
23. Twardowski ZJ: Treatment time and ultrafiltration rate are more important in dialysis prescription than small molecule clearance. Blood Purif 25:90-98, 2007.
24. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81:543-554, 2005.
25. Voroneanu L, Cusai C, Hogas S, et al: The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: Use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies. Int Urol Nephrol 42:789-797, 2010.
26. Wizemann V, Rode C, Wabel P: Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol 161:115-118, 2008.
27. Machek P, Jirka T, Moissl U, et al: Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant 25:538-544, 2010.
28. D'Amico M, Locatelli F: Hypertension in dialysis: Pathophysiology and treatment. J Nephrol 15:438-445, 2002.